Ga-66 labeled DOTA-E(c(RGDfK))(2) and NODAGA-E(c(RGDfK))(2) to target tumors over-expressing alpha(v)beta(3) integrin receptors


Por: Lopez-Rodriguez, V, Gaspar-Carcamo, RE, Lara-Camacho, VM, Avila-Garcia, M, Ferro-Flores, G, Pedraza-Lopez, M, de Murphy, CA, Avila-Rodriguez, MA

Publicada: 1 may 2013
Resumen:


Filiaciones:
Lopez-Rodriguez, V:
 Univ Nacl Autonoma Mexico, Fac Med, Unidad PET, Mexico City 04510, DF, Mexico

Gaspar-Carcamo, RE:
 Univ Nacl Autonoma Mexico, Fac Med, Unidad PET, Mexico City 04510, DF, Mexico

Lara-Camacho, VM:
 Univ Nacl Autonoma Mexico, Fac Med, Unidad PET, Mexico City 04510, DF, Mexico

Avila-Garcia, M:
 Univ Nacl Autonoma Mexico, Fac Med, Unidad PET, Mexico City 04510, DF, Mexico

Ferro-Flores, G:
 Inst Nacl Invest Nucl, Mexico City, Estado De Mexic, Mexico

Pedraza-Lopez, M:
 Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico

de Murphy, CA:
 Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico

Avila-Rodriguez, MA:
 Univ Nacl Autonoma Mexico, Fac Med, Unidad PET, Mexico City 04510, DF, Mexico
ISSN: 03624803





JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Editorial
John Wiley & Sons Inc., THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 56 Número: 1
Páginas: 356-356
WOS Id: 000318694100357